Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Copaxone
Pharma
Teva takes $215M hit from currency effects
Even as Teva CEO Kåre Schultz works to usher the company through a mass of opioid litigation and a heavy debt load, he’s now facing a new challenge.
Eric Sagonowsky
Nov 3, 2022 9:25am
The early findings of an EC investigation look bad for Teva
Oct 10, 2022 9:36am
'The Top Line' podcast: Layoff trends, generics sales and more
Jul 22, 2022 6:00am
J&J's Momenta calls infringement against Mylan and its partners
May 25, 2022 8:59am
Teva faces $100M claim by Israel over Copaxone royalties: report
May 11, 2022 8:50am
Teva CEO Schultz's pay falls 7% to $14.7M amid sales slump
Mar 17, 2022 7:38pm